Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

981 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and factors associated with tuberculosis infection in India.
Selvaraju S, Velayutham B, Rao R, Rade K, Thiruvengadam K, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chopra V, Das D, Dutta S, Devi KR, Dwivedi GR, Kalliath A, Laxmaiah A, Madhukar M, Mahapatra A, Mohanty SS, Rangaraju C, Turuk J, Menon PA, Krishnan R, Singh M, Sekar K, Robinson A, Turuk A, Krishnan NN, Srinivasan N, Rexy C, Suresh M, Hanna LE, Choudhury AH, Parmar M, Ramachandran R, Kumar N, Joshi RP, Narasimhaiah S, Chandrasekaran P, Khan AM, Panda S, Bhargava B; National TB Prevalence Survey Group. Selvaraju S, et al. Among authors: parmar m. J Infect Public Health. 2023 Dec;16(12):2058-2065. doi: 10.1016/j.jiph.2023.10.009. Epub 2023 Oct 13. J Infect Public Health. 2023. PMID: 37948837 Free article.
Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?
Nagaraja SB, Kumar AM, Sachdeva KS, Ramachandran R, Satyanarayana S, Bansal A, Parmar M, Chadha S, Nair S, Kumar A, Hinderaker SG, Edginton M, Dewan PK. Nagaraja SB, et al. Among authors: parmar m. PLoS One. 2012;7(9):e45554. doi: 10.1371/journal.pone.0045554. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23029092 Free PMC article.
Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
Dave P, Vadera B, Kumar AM, Chinnakali P, Modi B, Solanki R, Patel P, Patel P, Pujara K, Nimavat P, Shah A, Bharaswadkar S, Rade K, Parmar M, Nair SA. Dave P, et al. Among authors: parmar m. PLoS One. 2015 Apr 13;10(4):e0121996. doi: 10.1371/journal.pone.0121996. eCollection 2015. PLoS One. 2015. PMID: 25874545 Free PMC article.
Airborne infection control in India: Baseline assessment of health facilities.
Parmar MM, Sachdeva KS, Rade K, Ghedia M, Bansal A, Nagaraja SB, Willis MD, Misquitta DP, Nair SA, Moonan PK, Dewan PK. Parmar MM, et al. Indian J Tuberc. 2015 Oct;62(4):211-7. doi: 10.1016/j.ijtb.2015.11.006. Epub 2016 Jan 23. Indian J Tuberc. 2015. PMID: 26970461 Free PMC article.
Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
Parmar MM, Sachdeva KS, Dewan PK, Rade K, Nair SA, Pant R, Khaparde SD. Parmar MM, et al. PLoS One. 2018 Apr 11;13(4):e0193903. doi: 10.1371/journal.pone.0193903. eCollection 2018. PLoS One. 2018. PMID: 29641576 Free PMC article.
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India.
Moonan PK, Nair SA, Agarwal R, Chadha VK, Dewan PK, Gupta UD, Ho CS, Holtz TH, Kumar AM, Kumar N, Kumar P, Maloney SA, Mase SR, Oeltmann JE, Paramasivan CN, Parmar MM, Rade KK, Ramachandran R, Rao R, Salhorta VS, Sarin R, Sarin S, Sachdeva KS, Selvaraju S, Singla R, Surie D, Tonsing J, Tripathy SP, Khaparde SD. Moonan PK, et al. Among authors: parmar mm. BMJ Glob Health. 2018 Oct 8;3(5):e001135. doi: 10.1136/bmjgh-2018-001135. eCollection 2018. BMJ Glob Health. 2018. PMID: 30364389 Free PMC article.
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis.
Salhotra VS, Sachdeva KS, Kshirsagar N, Parmar M, Ramachandran R, Padmapriyadarsini C, Patel Y, Mehandru L, Jaju J, Ponnuraja C, Gupta M, Kalaiselvan V, Shamim A, Khaparde S, Swaminathan S; Bedaquiline CAP Site Teams. Salhotra VS, et al. Among authors: parmar m. Indian J Tuberc. 2020 Jan;67(1):29-37. doi: 10.1016/j.ijtb.2019.10.002. Epub 2019 Oct 16. Indian J Tuberc. 2020. PMID: 32192613
Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020).
Sachdeva KS, Parmar M, Patel Y, Gupta R, Rathod S, Chauhan S, Anand S, Ramachandran R. Sachdeva KS, et al. Among authors: parmar m. Expert Rev Respir Med. 2021 Jul;15(7):885-898. doi: 10.1080/17476348.2021.1850277. Epub 2021 Jan 21. Expert Rev Respir Med. 2021. PMID: 33307889 Review.
981 results